GSK-189254
Modify Date: 2024-04-05 15:43:42
GSK-189254 structure
|
Common Name | GSK-189254 | ||
|---|---|---|---|---|
| CAS Number | 945493-87-8 | Molecular Weight | 387.90300 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H26ClN3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide,hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C21H26ClN3O2 |
|---|---|
| Molecular Weight | 387.90300 |
| Exact Mass | 387.17100 |
| PSA | 57.95000 |
| LogP | 4.50130 |
|
~77%
GSK-189254 CAS#:945493-87-8 |
| Literature: GLAXO GROUP LIMITED Patent: WO2008/104589 A1, 2008 ; Location in patent: Page/Page column 12 ; |
| 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide hydrochloride |
| UNII-4AJV79N1A6 |
| GSK-189254 |